217
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

, , &
Pages 33-36 | Published online: 19 Dec 2018

References

  • TanEKLumSYFook-ChongSBehind the facial twitch: depressive symptoms in hemifacial spasmParkinsonism Relat Disord200511424124515878585
  • TanEKJankovicJPsychogenic hemifacial spasmJ Neuropsychiatry Clin Neurosci200113338038411514645
  • GillHSKraftSPLong-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasmCan J Neurol Sci201037563163621059510
  • The Cranial Nerve Disease Center, Shanghai Jiaotong UniversityChinese expert consensus on the diagnosis and treatment of HFSChin J Minim Invasive Neurosurg20141911528532
  • CummingsJLDepression and Parkinson’s disease: a reviewAm J Pyschiatry19921492443454
  • WangXDWangXLMaHMental Health Assessment Scale ManualChinese Mental Health Journal PressBeijing1999194197235238
  • KolarDAddictive potential of novel treatments for refractory depression and anxietyNeuropsychiatr Dis Treat2018141513151929928123
  • TanEKFook-ChongSLumSYLimEBotulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30)J Neurol Sci20042191–215115515050451
  • BurnDJBeyond the iron mask: towards better recognition and treatment of depression associated with Parkinson’s diseaseMov Disord200217344545412112190
  • CummingsJLDepression and Parkinson’s disease: a reviewAm J Pyschiatry19921492443454
  • StreitováHBarešMLong-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 yearsActa Neurol Belg2014114428529124604684
  • SetthawatcharawanichSSathirapanyaPLimapichatKPhabphalKLimIFactors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxinQual Life Res20112091519152321431990
  • HallTAMcGwinGSearceyKHealth-related quality of life and psychosocial characteristics of patients with benign essential blepharospasmArch Ophthalmol2006124111611916401794
  • SohnYHVollerBDimyanMCortical control of voluntary blinking: a transcranial magnetic stimulation studyClin Neurophysiol2004115234134714744575
  • HanakawaTDimyanMAHallettMThe representation of blinking movement in cingulate motor areas: a functional magnetic resonance imaging studyCereb Cortex200818493093717652462
  • Esmaeli-GutsteinBNahmiasCThompsonMKazdanMHarveyJPositron emission tomography in patients with benign essential blepharospasmOphthalmic Plast Reconstr Surg199915123279949425
  • HutchinsonMNakamuraTMoellerJRThe metabolic topography of essential blepharospasm: a focal dystonia with general implicationsNeurology200055567367710980732
  • Barahona-CorrêaBBugalhoPGuimarãesJXavierMObsessive-compulsive symptoms in primary focal dystonia: a controlled studyMov Disord201126122274227821830232
  • MunhozRPTeiveHADella ColettaMVFrequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasmArq Neuropsiquiatr2005632A21321616100964
  • BiukDKarinAAMatićSBaraćJBenasićTStiglmayerNQuality of life in patients with blepharospasmColl Antropol2013371293323697247
  • EmanAMMahmoudMEEffect of aerobic exercises versus foot reflexology on post-menopausal depressionClin Exp Obstet Gynecol2017445726729
  • WollmerMANeumannIMagidMKrugerTHShrink that frown! Botulinum toxin therapy is lifting the face of psychiatryG Ital Dermatol Venereol2018153454054829667799
  • LewisMBThe interactions between botulinum-toxin-based facial treatments and embodied emotionsSci Rep2018811472030283017